Caplight Directory>Investors>Heartland Healthcare Capital>Heartlandhealthcarecapital-vdtrxn


Heartland Healthcare Capital

Heartland Healthcare Capital

Minneapolis, Minnesotaheartlandhealthcarecapital.vdtrxn

Overview

Piper Heartland Healthcare Capital aligns the knowledge, expertise and capital of Piper Sandler with the interests of our limited partners to invest in innovative healthcare companies at key moments in their growth path. Building on the industry knowledge and capital markets expertise of Piper Sandler's leading healthcare banking and research platforms, the Piper Heartland Healthcare Crossover Fund invests primarily in biotech, med-tech and healthcare information sectors. The firm focuses on innovative companies with near-term public markets prospects, driven by experienced management teams and backed by highly respected investment partners.

AUM

$232.3M

Portfolio Companies

16

Investments

CompanyDateStageLead
Saluda MedicalJan 2025VC RoundCo-investor
Alentis TherapeuticsNov 2024Series DCo-investor
Endeavor BiomedicinesApr 2024Series CCo-investor
AlumisMar 2024Series CCo-investor
Profound BioFeb 2024Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMinneapolis, Minnesota
Year FoundedN/A
AUM$232.3M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.